Our study sought to delineate the antioxidation mechanism by which C+P induces neuroprotective effects by assessing the PKC-δ/NOX/MnSOD pathway, as well as the capacity of these drugs to repair oxidative damage after ischemic stroke. The gene discussed is PRKCD; the disease is ischemic stroke.